Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies
Open Access
- 16 December 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 136 (52) , 18034-18043
Abstract
This article reports the design, synthesis, and evaluation of a novel class of molecules of intermediate size (approximately 7000 Da), which possess both the targeting and effector functions of antibodies. These compounds—called synthetic antibody mimics targeting prostate cancer (SyAM-Ps)—bind simultaneously to prostate-specific membrane antigen and Fc gamma receptor I, thus eliciting highly selective cancer cell phagocytosis. SyAMs have the potential to combine the advantages of both small-molecule and biologic therapies, and may address many drawbacks associated with available treatments for cancer and other diseases.Keywords
Funding Information
- Bristol-Myers Squibb (OCR4997.11)
- National Institute of General Medical Sciences (GM100283-01)
This publication has 76 references indexed in Scilit:
- Reprogramming Urokinase into an Antibody-Recruiting Anticancer AgentACS Chemical Biology, 2011
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- Development of antibody surrogates for the treatment of cancers and autoimmune diseaseCurrent Opinion in Chemical Biology, 2010
- A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small MoleculesJournal of the American Chemical Society, 2010
- Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosisBritish Journal of Cancer, 2009
- Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate CancerJournal of the American Chemical Society, 2009
- An Antibody-Recruiting Small Molecule That Targets HIV gp120Journal of the American Chemical Society, 2009
- Role of chaperones and FcγR in immunogenic deathCurrent Opinion in Immunology, 2008
- Properties, production, and applications of camelid single-domain antibody fragmentsApplied Microbiology and Biotechnology, 2007
- Role for CD47-SIRPα signaling in xenograft rejection by macrophagesProceedings of the National Academy of Sciences, 2007